Molecular flexibility and the electrostatic moments of curcumin and its derivatives in the active site of p300: a theoretical charge density study.

B. Devipriya,P. Kumaradhas

DOI: https://doi.org/10.1016/j.cbi.2013.05.002

IF: 5.168

2013-08-25

Chemico-Biological Interactions

Abstract:

What problem does this paper attempt to address?

Human potential phases in the second half of life.

G. Cohen

DOI: https://doi.org/10.1097/00019442-199902000-00001

1999-12-01

Abstract:
Length of Stay, Hospital Costs and Mortality Associated with Comorbidity According to the Charlson Comorbidity Index in Immobile Patients after Ischemic Stroke in China: A National Study.

Hongpeng Liu,Baoyun Song,Jingfen Jin,Yilan Liu,Xianxiu Wen,Shouzhen Cheng,Stephen Nicholas,Elizabeth Maitland,Xinjuan Wu,Dawei Zhu

DOI: https://doi.org/10.34172/ijhpm.2021.79

2021-01-01

International Journal of Health Policy and Management

Abstract:Background: In this study, we examined the length of stay (LoS)-predictive comorbidities, hospital costs-predictive comorbidities, and mortality-predictive comorbidities in immobile ischemic stroke (IS) patients; second, we used the Charlson Comorbidity Index (CCI) to assess the association between comorbidity and the LoS and hospitalization costs of stroke; third, we assessed the magnitude of excess IS mortality related to comorbidities. Methods: Between November 2015 and July 2017, 5114 patients hospitalized for IS in 25 general hospitals from six provinces in eastern, western, and central China were evaluated. LoS was the period from the date of admission to the date of discharge or date of death. Costs were collected from the hospital information system (HIS) after the enrolled patients were discharged or died in hospital. The HIS belongs to the hospital's financial system, which records all the expenses of the patient during the hospital stay. Cause of death was recorded in the HIS for 90 days after admission regardless of whether death occurred before or after discharge. Using the CCI, a comorbidity index was categorized as zero, one, two, and three or more CCI diseases. A generalized linear model with a gamma distribution and a log link was used to assess the association of LoS and hospital costs with the comorbidity index. Kaplan-Meier survival curves was used to examine overall survival rates. Results: We found that 55.2% of IS patients had a comorbidity. Prevalence of peripheral vascular disease (21.7%) and diabetes without end-organ damage (18.8%) were the major comorbidities. A high CCI=3+ score was an effective predictor of a high risk of longer LoS and death compared with a low CCI score; and CCI=2 score and CCI=3+ score were efficient predictors of a high risk of elevated hospital costs. Specifically, the most notable LoS-specific comorbidities, and cost-specific comorbidities was dementia, while the most notable mortality-specific comorbidities was moderate or severe renal disease. Conclusion: CCI has significant predictive value for clinical outcomes in IS. Due to population aging, the CCI should be used to identify, monitor and manage chronic comorbidities among immobile IS populations. Copyright: (c) 2021 The Author(s); Published by Kerman University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/ by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Citation: Liu H, Song B, Jin J, et al. Length of stay, hospital costs and mortality associated with comorbidity according to the Charlson comorbidity index in immobile patients after ischemic stroke in China: a national study. Int J Health
COVID-19 burden in Iran: disability-adjusted life years analysis from hospital data, 2020-2021

Soheila Damiri,Mahshad Goharimehr,Mohammad Mahdi Nasehi,Mohammad Effatpanah,Zahra Shahali,Hossein Ranjbaran,Rajabali Daroudi

DOI: https://doi.org/10.1186/s13690-024-01355-9

2024-08-26

Abstract:Background: The burden of disease based on disability-adjusted life years (DALYs) is one of the internationally accepted metrics for assessing the impact of a disease or injury on population health. This study aimed to provide evidence of the burden of COVID-19 on health in Iran based on hospital-level data from the Iran Health Insurance Organization (IHIO), which covers almost half of the country's population. Methods: The data of all IHIO enrollees who were referred to hospitals across the country from the beginning of the COVID-19 pandemic (February 2020) to December 30, 2021, with assigned diagnosis codes of COVID-19, were extracted from the hospital information processing system. The DALYs due to COVID-19 were estimated using the standard approach of the World Health Organization and the European Burden of Disease Network guideline. Results: In the years 2020 and 2021, among a population of about 42 million people, 1,040,367 individuals were admitted to the hospital due to COVID-19 infection, of whom 73% were hospitalized (760,963 patients). The total estimated DALYs for these two years were 665,823 and 928,393, respectively (1,603 and 2,234 per 100,000 population). 99.7% of DALYs were attributed to years of life lost due to premature death (YLLs). The share of the disease burden in the age groups of under 20 years, 20-49 years, 50-80 years, and over 80 years was 6.6%, 26.4%, 58.4%, and 8.6%, respectively. Conclusions: Based on the hospital-level data estimates, COVID-19 has had a significant burden on health in Iran. COVID-19 was identified as the fifth leading cause of disease burden in Iran during the study period, ranking after cardiovascular diseases, psychological disorders, neoplasms, and musculoskeletal disorders. Additionally, COVID-19 was the third major cause of death, following cardiovascular diseases and neoplasms. Policymaking and the implementation of comprehensive programs to enhance the response of the health system and society to outbreaks of emerging and re-emerging infectious diseases are of utmost importance.
Competition under a regime of imperfect risk adjustment: The Swiss experience

K. Beck

DOI: https://doi.org/10.1007/BF01299235

Sozial- und Präventivmedizin

Abstract:
Burden of aortic aneurysm in Iran from 1990 to 2019: an analysis based on global burden of disease study

Milad Mellat-Ardakani,Kaveh Atighi,Shahryar Rahmani,Saba Simiyari,Faeze Salahshour

DOI: https://doi.org/10.1097/MS9.0000000000002356

2024-07-12

Abstract:Background: Limited studies have been conducted on the epidemiology of aortic aneurysms in Iran. In this study, the authors aimed to comprehensively evaluate the burden and epidemiology of aortic aneurysms across various age groups, sexes, and provinces in Iran from 1990 to 2019. Materials and methods: The authors used global burden of disease (GBD) study data in the current study. The authors retrieved data on the burden of aortic aneurysms across sexes and age groups at national and subnational levels from 1990 to 2019. The authors extracted mortality, years of life lost (YLL), years lived with disability (YLD), and disability-adjusted life year (DALY), numbers, rates, and age-standardized rates. Additionally, the authors extracted the burden of AA attributable to its risk factors, such as lead exposure, high systolic blood pressure, high dietary intake of sodium, and smoking. Results: National ASDR (age-standardized DALY rate) was also observed to be reduced from 1990 [22.20 (17.46-26.86)] to 2019 [19.97 (17.98-21.98)]. However, the inclinations were evaluated to be slighter than the world (%change ASDR=-19.5%). In 2019, three leading risk factors yielding death in AA patients were smoking [ASMR attributable=0.73 (0.67-0.80)], high sodium intake [ASMR attributable=0.11 (0.03-0.27)], and lead exposure [ASMR attributable=0.04 (0.02-0.07)]. Conclusion: Mortality and DALYs due to AA both decreased slightly during the last three decades. Considering the role of smoking in the burden of AA in Iran, interventions targeting smoking cessation among high-risk groups, such as males, may be helpful to reduce the burden of AA in Iran in the coming years.
Metabolic Syndrome and Ischemic Stroke in Iran: Incidence and Disability-Adjusted Life Years 1990 to 2019

Moslem Taheri-Soodejani,Marjan Rasoulian-Kasrineh,Seyyed-Mohammad Tabatabaei

DOI: https://doi.org/10.1089/met.2023.0253

2024-03-02

Metabolic Syndrome and Related Disorders

Abstract:Introduction: Metabolic syndrome (MS) is one of the conditions that may increase the risk of ischemic stroke (IS). This study focuses on factors of MS related to the incidence, years of life lost (YLL), and years of life disability (YLD) caused by IS. Materials and Methods: The age-adjusted data (incidence, YLL, and YLD) related to four factors of MS [fasting plasma glucose, body mass index (BMI), low-density lipoprotein, and systolic blood pressure, SBP] were extracted as risk factors for IS during the years 1990 to 2019 from global burden of disease study. ARC GIS V.10 software was used to investigate the geographical distribution and the Cochran–Armitage test was used to investigate the trend of these indices. Results: The highest incidence of IS was reported in Golestan provinces in 2019 [women: 180 (95% UI 153–213), men: 163 (95% UI 141–191), and both genders: 172 (95% UI 149–201)]. High SBP has the highest impact on YLD (96–102 per 100,000 population in some provinces) and YLL (688–824 per 100,000 population in some provinces) in men and women (YLD: 126–156, YLL: 586–785 per 100,000 population in some provinces). High BMI has increased YLD caused by IS from 1990 (35 per 100,000 population) to 2019 (53 per 100,000 population). Conclusion: Considering the importance of IS and the impact that MS has on this disease, it seems that one of the most effective possible measures is to eliminate MS. The factors of MS are mostly related to lifestyle, and MS can be controlled with a suitable plan, which can be considered as primary prevention for IS.

medicine, research & experimental
Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis

Mehdi Javanbakht,Atefeh Mashayekhi,Hamid R. Baradaran,AliAkbar Haghdoost,Ashkan Afshin

DOI: https://doi.org/10.1371/journal.pone.0132505

IF: 3.7

2015-07-22

PLoS ONE

Abstract:BACKGROUND: The aim of this study was to estimate the economic burden of diabetes mellitus (DM) in Iran from 2009 to 2030.METHODS: A Markov micro-simulation (MM) model was developed to predict the DM population size and associated economic burden. Age- and sex-specific prevalence and incidence of diagnosed and undiagnosed DM were derived from national health surveys. A systematic review was performed to identify the cost of diabetes in Iran and the mean annual direct and indirect costs of patients with DM were estimated using a random-effect Bayesian meta-analysis. Face, internal, cross and predictive validity of the MM model were assessed by consulting an expert group, performing sensitivity analysis (SA) and comparing model results with published literature and national survey reports. Sensitivity analysis was also performed to explore the effect of uncertainty in the model.RESULTS: We estimated 3.78 million cases of DM (2.74 million diagnosed and 1.04 million undiagnosed) in Iran in 2009. This number is expected to rise to 9.24 million cases (6.73 million diagnosed and 2.50 million undiagnosed) by 2030. The mean annual direct and indirect costs of patients with DM in 2009 were US$ 556 (posterior standard deviation, 221) and US$ 689 (619), respectively. Total estimated annual cost of DM was $3.64 (2009 US$) billion (including US$1.71 billion direct and US$1.93 billion indirect costs) in 2009 and is predicted to increase to $9.0 (in 2009 US$) billion (including US$4.2 billion direct and US$4.8 billion indirect costs) by 2030.CONCLUSIONS: The economic burden of DM in Iran is predicted to increase markedly in the coming decades. Identification and implementation of effective strategies to prevent and manage DM should be considered as a public health priority.

multidisciplinary sciences
Straw men and strange logic: issues and pseudo-issues in special education.

F. Symons,S. Warren

DOI: https://doi.org/10.1037//0003-066X.53.10.1160

IF: 16.358

American Psychologist

Abstract:
Trend and projection of non-communicable diseases risk factors in Iran from 2001 to 2030

Farshad Farzadfar,Moein Yousefi,Ali Jafari-Khounigh,Zahra Khorrami,AliAkbar Haghdoost,Fatemeh Khosravi Shadmani

DOI: https://doi.org/10.1038/s41598-024-58629-z

IF: 4.6

2024-04-08

Scientific Reports

Abstract:This study aims to investigate the trends and project the major risk factors of Non-communicable Diseases (NCDs) in Iran. We obtained the trend of prevalence of main risk factors related to NCDs in 30 to 70-year-old-individuals. The data were extracted from WHO STEP wise approach to NCDs risk factor surveillance (STEPS) survey. Also,the previous studies conducted at national and subnational levels from 2001 to 2016 were employed. The prevalence of risk factors was projected by 2030 using Bayesian Model Averaging (BMA) and Spatio-temporal model stratified by sex and province. The percent change for the age-standardized prevalence of smoking in men between 2001 and 2016 was calculated to be − 27.0. Also, the corresponding values for the risk factors of diabetes, hypertension, obesity and overweight, physical inactivity (PI), and mean of salt intake were − 26.1, 29.0, 70.0, 96.8, 116.6, and 7.5, respectively. It is predicted that smoking and these risk factors will undergo a change to show values of − 1.26, 38.7, 43.7, 2.36, and 15.3 by 2030, respectively. The corresponding values in women for the time interval of 2001–2016 were − 27.3, 26.3, 82.8, 1.88, 75.2, and 4.2, respectively. Plus, projections indicate that the 2030 variation values are expected to be − 25.0, 16.7, 37.5, 28.7, 26.7, and 10.9 respectively. This study showed that the prevalence of four risk factors of PI, overweight and obesity, hypertension, and diabetes is increasing in Iran. Therefor, it is necessary to carry out effective interventions to adopt a healthy lifestyle and reduce the risk factors.

multidisciplinary sciences
Spatial Variation in Sympathetic Influences on the Vasculature of the Synovium and Medial Collateral Ligament of the Rabbit Knee Joint

J. McDougall,W. Ferrell,R. Bray

DOI: https://doi.org/10.1111/j.1469-7793.1997.435bh.x

1997-09-01

Journal of Physiology

Abstract:1 Laser Doppler perfusion imaging was used to assess the role of the sympathetic nervous system in the control of blood flow to the medial collateral ligament and capsule (synovium and overlying fibrous tissues) of the rabbit knee joint. 2 Electrical stimulation of the saphenous nerve (width 1 ms; amplitude 20V; 1–30 Hz) produced a frequency‐dependent vasoconstriction of knee joint vasculature. The response was maximal at 30 Hz and gave the greatest fall in perfusion at the femoral insertion of the ligament (by 33.8 ± 7.4%, mean ±s.e.m.; n= 5–6) and the smallest decrease at the tibial insertion of the ligament (by 10.6 ± 2.9%). 3 Topical application of phentolamine (10−6 mol) had no significant effect on basal knee joint blood flow. However, it abolished the nerve‐mediated constrictor responses in all regions of the medial collateral ligament and synovium at all frequencies. 4 Topical administration of adrenaline (10−14 to 10−7 mol) caused a dose‐dependent decrease in knee joint blood flow with the highest dose producing > 75% reduction in perfusion at all areas. 5 There was no evidence of a reactive hyperaemia in the 5 min following a 5 min period of femoral artery occlusion. Artificial manipulation of arterial blood pressure by intravenous infusion or withdrawal of blood caused a proportional change in ligament and synovial blood flow. These observations may indicate a lack of autoregulation in the joint and its exclusion from baroreflex modulation. 6 These results suggest a potential role for the sympathetic nervous system in the control of knee joint blood flow. Neuromodulation of ligament perfusion appears to predominate at the femoral insertion and this could prove to have functional significance.
An epidemiologic study of differences between mammary ductal and lobular carcinoma in situ: analysis of 11,436 cases from the California Cancer Registry.

S. Saltzstein

Abstract:
Epidemiology, burden, and attributable risks of infective endocarditis in Iran and its provinces: From 1990 to 2019

Ali Ajam,Parnian Shobeiri,Mohammad Keykhaei,Sahar Saeedi Moghaddam,Sara Momtazmanesh,Masoud Masinaei,Zahra Esfahani,Negar Rezaei,Mohammadreza Naderian,Arya Aminorroaya,Mohammad-Mahdi Rashidi,Nazila Rezaei,Bagher Larijani,Elaheh Malakan Rad,Farshad Farzadfar

DOI: https://doi.org/10.1016/j.ijcard.2022.06.060

2022-09-15

Abstract:Background: Endocarditis is a potentially life-threatening infectious disease associated with significant morbidity and mortality and an escalating incidence in recent decades. In this study, as a part of the global burden of disease (GBD) 2019 study, we intend to report endocarditis burden in Iran at national and provincial levels from 1990 to 2019. Method: This study was conducted using GBD 2019 study data on endocarditis from 1990 to 2019. We gathered incidence, prevalence, disability-adjusted life years (DALYs), and mortality rates in Iran and its 31 provinces by sex and age groups as epidemiological indices for endocarditis burden. Further decomposition analysis was also performed to delineate the endocarditis new cases trend. Results: On the country scale, age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized DALYs rate were (16.5 (95% uncertainty interval 13.7 to 19.8), 3.4 (2.9 to 4.1), 0.6 (0.5 to 0.9), and 14.4 (12.0 to 21.1) in 2019, respectively. Decomposition analysis showed that only 59.2% of the overall new cases increase (114.1%) was caused by the incidence rate change. All estimated age-standardized rates were higher in men in 1990 and 2019 with a ratio of 1.1-1.5. Conclusion: The ASIR and ASPR of endocarditis increased, and the ASMR and age-standardized DALYs rate declined over the past 30 years in Iran, nearly all the provinces followed the same pattern with North Khorasan having the Highest ASIR, ASPR, ASMR, and DALYs rates in both years. High systolic blood pressure (SBP) had the greatest attributed burden among risk factors.
Multimorbidity and associations with clinical outcomes in a middle-aged population in Iran: a longitudinal cohort study

Maria Lisa Odland,Samiha Ismail,Sadaf G Sepanlou,Hossein Poustchi,Alireza Sadjadi,Akram Pourshams,Tom Marshall,Miles D Witham,Reza Malekzadeh,Justine I Davies

DOI: https://doi.org/10.1136/bmjgh-2021-007278

IF: 8.056

2022-05-01

BMJ Global Health

Abstract:Background As the populations of lower-income and middle-income countries age, multimorbidity is increasing, but there is little information on its long-term consequences. We aimed to show associations between multimorbidity and outcomes of mortality and hospitalisation in Iran, a middle-income country undergoing rapid economic transition. Methods We conducted a secondary analysis of longitudinal data collected in the Golestan Cohort Study. Data on demographics, morbidities and lifestyle factors were collected at baseline, and information on hospitalisations or deaths was captured annually. Logistic regression was used to analyse the association between baseline multimorbidity and 10-year mortality, Cox-proportional hazard models to measure lifetime risk of mortality and zero-inflation models to investigate the association between hospitalisation and multimorbidity. Multimorbidity was classified as ≥2 conditions or number of conditions. Demographic, lifestyle and socioeconomic variables were included as covariables. Results The study recruited 50 045 participants aged 40–75 years between 2004 and 2008, 47 883 were available for analysis, 416 (57.3%) were female and 12 736 (27.94%) were multimorbid. The odds of dying at 10 years for multimorbidity defined as ≥2 conditions was 1.99 (95% CI 1.86 to 2.12, p<0.001), and it increased with increasing number of conditions (OR of 3.57; 95% CI 3.12 to 4.08, p<0.001 for ≥4 conditions). The survival analysis showed the hazard of death for those with ≥4 conditions was 3.06 (95% CI 2.74 to 3.43, p<0.001). The number of hospital admissions increased with number of conditions (OR of not being hospitalised of 0.36; 95% CI 0.31 to 0.52, p<0.001, for ≥4 conditions). Conclusion The long-terms effects of multimorbidity on mortality and hospitalisation are similar in this population to those seen in high-income countries.

public, environmental & occupational health
A history of smoking is associated with improved survival in patients treated with mild therapeutic hypothermia following cardiac arrest.

Jeremy S. Pollock,Ryan D. Hollenbeck,Li Wang,D. Janz,T. Rice,J. Mcpherson

DOI: https://doi.org/10.1016/j.resuscitation.2013.08.275

IF: 6.251

Resuscitation

Abstract:
Prediction the burden of COVID-19 in Iran: Application of disability-adjusted life years (DALYs)

Negar Mirzaee,Mohsen Barouni,Reza Goudarzi,Yunes Jahani,AliAkbar Haghdoost,Milad Ahmadi Gohari,Mehran Nakhaeizadeh,Willi McFarland,Hamid Sharifi

DOI: https://doi.org/10.21203/rs.3.rs-78334/v1

2020-09-21

Abstract:Abstract Background The novel Coronavirus disease 2019 (COVID-19) rapidly became the world’s largest threat to health and the economy in recent times. Prediction of the COVID-19 pandemic’s full impact is a necessary gauge for future policy making, including resource allocation for prevention, mitigation, and control preparedness. Methods We used the extended form of the Susceptible-Exposed-Infected/Infectious-Recovered/Removed (SEIR) model to predict new cases and number of deaths associated to COVID-19. Data from the Ministry of Health and Medical Education of Iran provided relevant parameters for predicting disability-adjusted life years (DALYs). We conducted a review of the literature on COVID-19-like diseases to develop disability weights (DWs) and convened an expert panel to verify their applicability. Beta-PERT distributions were used to calculate DWs for age groups. The minimum and maximum values were 0 and 0.14 for mild to severe disability, respectively. Results The total DALYs for COVID-19 in Iran predicted by our model will be 973 per 100,000 populations from January, 2020 to January, 2021. Overall, 957 years per 100,000 will be from YLLs (98.4% of DALYs) and 16 will be from YLDs (1.6% of DALY). The total DALYs in men will be 1,082 years per 100,000 and 861 per 100,000 in women. Conclusions Our predictions of COVID-19 burden will be useful in determining health priorities and to appropriately allocate resources to prepare for future outbreaks of COVID-19 and similar diseases. We hope this study will contribute to evidence-based health policy making in Iran.
Global burden of ischaemic heart disease from 2022 to 2050: projections of incidence, prevalence, deaths, and disability-adjusted life years

Hujuan Shi,Yihang Xia,Yiran Cheng,Pengcheng Liang,Mingmei Cheng,Baoliang Zhang,Zhen Liang,Yanzhong Wang,Wanqing Xie

DOI: https://doi.org/10.1093/ehjqcco/qcae049

2024-06-25

European Heart Journal - Quality of Care and Clinical Outcomes

Abstract:Abstract Aims Ischaemic heart disease (IHD) has been a significant public health issue worldwide. This study aims to predict the global burden of IHD in a timely and comprehensive manner. Methods and results Incidence, prevalence, deaths, and disability-adjusted life years (DALYs) for IHD from 1990 to 2021 were derived from the Global Burden of Disease 2021 database, and three models (linear, exponential, and Poisson regression) were used to estimate their trends over time at the global, regional, and national levels by age, sex, and country groups, with the gross domestic product per capita was applied to adjust the model. The model results revealed that the global burden of IHD is expected to increase continuously by 2050. By 2050, global IHD incidence, prevalence, deaths, and DALYs are projected to reach 67.3 million, 510 million, 16 million, and 302 million, respectively, which represents an increase of 116%, 106%, 80%, and 62%, respectively, from 2021. Moreover, the results showed that regions with lower sociodemographic index (SDI) bore a greater burden of IHD than those with higher SDI, with men having a higher burden of IHD than women. People over 70 years old account for a major part of the burden of IHD, and premature death of IHD is also becoming more serious. Conclusion The global burden of IHD will increase further by 2050, potentially due to population ageing and economic disparities. Hence, it is necessary to strengthen the prevention of IHD and formulate targeted strategies according to different SDI regions and special populations.

cardiac & cardiovascular systems
Global Burden of Ischemic Heart Disease and Attributable Risk Factors, 1990-2017: A Secondary Analysis Based on the Global Burden of Disease Study 2017

Fang Wang,Yong Yu,Sumaira Mubarik,Yu Zhang,Xiaoxue Liu,Yao Cheng,Chuanhua Yu,Jinhong Cao

DOI: https://doi.org/10.2147/CLEP.S317787

2021-01-01

Clinical Epidemiology

Abstract:Objective: To estimate the burden of ischemic heart disease (IHD) stratified by gender, geographic location, and social-demographic status for 21 regions across the world 1990 to 2017. Methods: Using the Global Burden of Disease Study (GBD) Results Tool, we extracted on the incidence, mortality, disability-adjusted life years (DALYs), and age-standardized rates related to IHD, as IHD burden measures. Trend analyzes were conducted for regions. Risk factors for DALYs (obtained from the GBD comparative risk assessment framework) were also analyzed. Results: Globally, 10.6 million (95% uncertainty interval [UI]: 9.6-11.8) cases of IHD in 2017, with 8.9 million (95%UI:8.8-9.1) IHD-related deaths. Both the age-standardized incidence rate (ASIR) and death rate (ASDR) declined from 1990 to 2017 (percentage 27.4% and 30.0%, respectively), with average annual percent change (AAPC) values and -1.3%, respectively. In 2017, the global number of IHD-related DALYs was 170.3 (95%UI:167.1-174.0), and the middle socio-demographic index (SDI) quintile contributed most to these DALYs. In most regions, indicators (incidence, mortality, and DALYs) steadily with SDI increased. High systolic blood pressure (SBP) was the most significant contributor to the DALYs in most regions, accounting for 118.18 million DALYs globally, followed by high low-density lipoprotein cholesterol and a diet low in nuts and (101.78 and 52.86 million, respectively). Conclusion: Even though the trend in IHD morbidity and mortality decreased globally, burden remains high, particularly in regions with lower SDI. It is necessary to learn successful and effective experience in controlling IHD risks and decreasing health disparities to reduce IHD burden.
Estimating the burden of atrial fibrillation and atrial flutter with projection to 2050 in Iran

Hamidreza Soleimani,Kiarash Tavakoli,Amir Nasrollahizadeh,Sina Azadnajafabad,Mahtab Mashayekhi,Pouya Ebrahimi,Farzad Masoudkabir,Ali Vasheghani-Farahani,Kaveh Hosseini

DOI: https://doi.org/10.1038/s41598-024-71296-4

2024-08-31

Abstract:Atrial fibrillation (AF)/atrial flutter (AFL) is the most common cardiac tachyarrhythmia, with an increasing trend in its burden in recent years. However, the burden of AF/AFL in Iran remains unclear. This study aimed to estimate the burden of AF/AFL and its attributable risk factors from 1990 to 2019 at national and subnational levels. Using the comparative risk assessment method of the Global Burden of Disease (GBD) Study 2019, we extracted data on AF/AFL incidence, prevalence, deaths, disability-adjusted life years (DALYs), and their age-standardized rates from 1990 to 2019 and analyzed them based on by age, sex, and socio-demographic index (SDI). The percentage contribution of AF/AFL major risk factors was calculated. Moreover, the AF/AFL burden in 2050 was projected using the United Nations world population prospect data. In 2019, there were 339.1 (259.4-433.7) thousand AF/AFL patients in Iran, with 30.2 (23.2-38.5) thousand new cases, 1.7 (1.5-2) thousand deaths and 48 (37.7-60.5) thousand DALYs. Females and 50-69-year-old patients recorded a higher burden for AF/AFL; however, the increasing trend was more pronounced in males and more than 85-year-old patients. High systolic blood pressure and elevated body mass index (BMI) were the predominant attributable risk factors for AF/AFL-related deaths and DALYs. It is estimated that in 2050, the number of AF/AFL patients will increase to 1.1 million people, the incidence of AF/AFL will increase to 91 thousand patients, and the number of AF/AFL-related deaths and DALYs will surge to 7.2 and 170.8 thousand, respectively. Despite advancements in prevention and treatment, AF/AFL remains a major public health problem in Iran. Given its largely preventable and treatable nature, more cost-effective strategies are required to target modifiable risk factors, especially within susceptible age and sex groups.
Analysis of readmission and hospitalization expenditures of patients with ischemic stroke suffering from different comorbidities

Honghong Feng,Jiachi Zhang,Zhenhua Qin,Yi Zhu,Xiaodi Zhu,Lijin Chen,Zhengqi Lu,Yixiang Huang

DOI: https://doi.org/10.1016/j.heliyon.2024.e36462

IF: 3.776

2024-08-26

Heliyon

Abstract:Background: The comorbidities of ischemic stroke (IS) are increasing worldwide. This study aimed to quantitatively assess the effect of different types of comorbidity on readmission and hospitalization expenditures of patients with IS. Methods: A retrospective observational study was conducted from the basic insurance claims database of a large city in China, between January 1, 2018, and May 31, 2022. We identified patients with IS aged 18 years and over, who experienced the first episode of IS and had one-year follow-up records. This study divided eighteen different comorbid conditions into two categories (concordant comorbidity and discordant comorbidity) and the IS patients were further categorized into four groups. Multivariable logistic regression models and generalized linear models with log-link and gamma distribution were to estimate the effect of different comorbidity groups on one-year readmission rates and annual hospitalization expenditures. Results: In total, 99,649 adult patients with IS were identified. Approximately 94.0 % of patients with IS had at least one comorbidity, and 63.8 % reported concordant comorbidity only. Patients with IS had a readmission rate of 26.7 %, and the mean of annual hospitalization expenditure and annual hospitalization out-of-pocket expenditure (OOPE) were 28086.6 Chinese Yuan (CNY) and 8267.3 CNY, respectively. After adjustment for covariates, the concordant comorbidity-only group had the highest readmission rate, annual hospitalization expenditure, and OOPE compared with the other groups, furthermore, these results increased as the number of comorbidity increased and had statistically significant positive associations. Conclusions: The readmission and annual hospitalization expenditures of patients with IS were associated with different comorbidities. Concordant comorbidity increased hospital readmission risk and health expenditures. To better manage the comorbidities of patients with IS, especially concordant comorbidities, it is necessary to establish a routine care strategy specifically for comorbid conditions.
Epidemiology and predictors of multimorbidity in Kharameh cohort study: A population-based cross-sectional study in southern Iran

Leila Moftakhar,Ramin Rezaeianzadeh,Masoumeh Ghoddusi Johari,Seyed Vhid Hosseini,Abbas Rezaianzadeh

DOI: https://doi.org/10.1002/hsr2.988

2022-12-08

Abstract:Background and aim: Multimorbidity is one of the problems and concerns of public health. The aim of this study was to estimate the prevalence and identify the risk factors associated with multimorbidity based on the data of the Kherameh cohort study. Methods: This cross-sectional study was performed on 10,663 individuals aged 40-70 years in the south of Iran in 2015 to 2017. Demographic and behavioral characteristics were investigated. Multimorbidity was defined as the coexistence of two or more of two chronic diseases in a person. In this study, the prevalence of multimorbidity was calculated. Logistic regression was used to identify the predictors of multimorbidity. Results: The prevalence of multimorbidity was 24.4%. The age-standardized prevalence rate was 18.01% in males and 29.6% in females. The most common underlying diseases were gastroesophageal reflux disease with hypertension (33.5%). Multiple logistic regression results showed that the age of 45-55 years (adjusted odds ratio [ORadj]] = 1.22, 95% confidence interval [CI], 1.07-1.38), age of over 55 years (ORadj = 1.21, 95% CI, 1.06-1.37), obesity (ORadj = 3.65, 95% CI, 2.55-5.24), and overweight (ORadj = 2.92, 95% CI, 2.05-4.14) were the risk factors of multimorbidity. Also, subjects with high socioeconomic status (ORadj = 1.27, 95% CI, 1.1-1.45) and very high level of socioeconomic status (ORadj = 1.53, 95% CI, 1.31-1.79) had a higher chance of having multimorbidity. The high level of education, alcohol consumption, having job, and high physical activity had a protective role against it. Conclusion: The prevalence of multimorbidity was relatively high in the study area. According to the results of our study, age, obesity, and overweight had an important effect on multimorbidity. Therefore, determining interventional strategies for weight loss and control and treatment of chronic diseases, especially in the elderly, is very useful.

Molecular flexibility and the electrostatic moments of curcumin and its derivatives in the active site of p300: a theoretical charge density study.

Human potential phases in the second half of life.

Length of Stay, Hospital Costs and Mortality Associated with Comorbidity According to the Charlson Comorbidity Index in Immobile Patients after Ischemic Stroke in China: A National Study.

COVID-19 burden in Iran: disability-adjusted life years analysis from hospital data, 2020-2021

Competition under a regime of imperfect risk adjustment: The Swiss experience

Burden of aortic aneurysm in Iran from 1990 to 2019: an analysis based on global burden of disease study

Metabolic Syndrome and Ischemic Stroke in Iran: Incidence and Disability-Adjusted Life Years 1990 to 2019

Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis

Straw men and strange logic: issues and pseudo-issues in special education.

Trend and projection of non-communicable diseases risk factors in Iran from 2001 to 2030

Spatial Variation in Sympathetic Influences on the Vasculature of the Synovium and Medial Collateral Ligament of the Rabbit Knee Joint

An epidemiologic study of differences between mammary ductal and lobular carcinoma in situ: analysis of 11,436 cases from the California Cancer Registry.

Epidemiology, burden, and attributable risks of infective endocarditis in Iran and its provinces: From 1990 to 2019

Multimorbidity and associations with clinical outcomes in a middle-aged population in Iran: a longitudinal cohort study

A history of smoking is associated with improved survival in patients treated with mild therapeutic hypothermia following cardiac arrest.

Prediction the burden of COVID-19 in Iran: Application of disability-adjusted life years (DALYs)

Global burden of ischaemic heart disease from 2022 to 2050: projections of incidence, prevalence, deaths, and disability-adjusted life years

Global Burden of Ischemic Heart Disease and Attributable Risk Factors, 1990-2017: A Secondary Analysis Based on the Global Burden of Disease Study 2017

Estimating the burden of atrial fibrillation and atrial flutter with projection to 2050 in Iran

Analysis of readmission and hospitalization expenditures of patients with ischemic stroke suffering from different comorbidities

Epidemiology and predictors of multimorbidity in Kharameh cohort study: A population-based cross-sectional study in southern Iran